Mérieux Equity Partners, an European healthcare-specialized investment firm, agreed to acquire a majority stake in InnoSyn, a provider of outsourced process R&D services. Financial terms were not disclosed. “When we first met InnoSyn’s Management team, we were immediately impressed by their expertise and the unique positioning of the Company in its sector. We believe that InnoSyn, already being one of the European leaders, is still only at its beginning, providing enormous potential for further development through the continuation of its R&D services, where it has built true excellence, coupled with strategic expansion of its geographical coverage, and broadening its range of services to adjacent activities. We are excited to start collaborating with the Management team to accompany InnoSyn in its next development phase," Jaana Grüter and Theodor Wuppermannn, MxEP Partner and Managing Director.